Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AZTA

Azenta Inc

Apr 15 • 03:53PM ET

25.06

+0.80 3.30 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI IWM VB VBR VXF SPSM IWN IJT SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.27	Insider Own	1.06%	Shs Outstand	46.02M	Perf Week	12.38%
Market Cap	1.15B	Forward P/E	23.33	EPS next Y	1.07	Insider Trans	0.00%	Shs Float	45.58M	Perf Month	19.85%
Enterprise Value	796.78M	PEG	0.64	EPS next Q	0.12	Inst Own	114.22%	Short Float	11.64%	Perf Quarter	-34.90%
Income	-57.82M	P/S	1.94	EPS this Y	52.30%	Inst Trans	5.32%	Short Ratio	5.77	Perf Half Y	-17.88%
Sales	595.19M	P/B	0.67	EPS next Y	38.27%	ROA	1.41%	Short Interest	5.31M	Perf YTD	-24.65%
Book/sh	37.26	P/C	2.80	EPS next 5Y	36.38%	ROE	1.69%	52W High	41.73 -39.94%	Perf Year	-3.27%
Cash/sh	8.95	P/FCF	37.32	EPS past 3/5Y	40.29% -	ROIC	-3.27%	52W Low	19.87 26.13%	Perf 3Y	-45.66%
Dividend Est.	-	EV/EBITDA	16.26	Sales past 3/5Y	2.25% 8.85%	Gross Margin	45.30%	Volatility	6.38% 5.92%	Perf 5Y	-74.89%
Dividend TTM	-	EV/Sales	1.34	EPS Y/Y TTM	57.71%	Oper. Margin	-1.30%	ATR (14)	1.31	Perf 10Y	145.94%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.61	Sales Y/Y TTM	-8.36%	Profit Margin	-9.71%	RSI (14)	60.19	Recom	2.12
Dividend Gr. 3/5Y	- -	Current Ratio	2.92	EPS Q/Q	-14.91%	SMA20	14.82%	Beta	1.43	Target Price	35.57
Payout	-	Debt/Eq	0.03	Sales Q/Q	0.77%	SMA50	1.02%	Rel Volume	0.58	Prev Close	24.26
Employees	3000	LT Debt/Eq	0.03	Earnings	Feb 04 BMO	SMA200	-18.59%	Avg Volume	920.48K	Price	25.06
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-34.83% 1.06%	Trades		Volume	523,865	Change	3.30%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform	$50
Dec-19-25	Reiterated	Needham	Buy	$42 → $44
Oct-30-25	Upgrade	Jefferies	Hold → Buy	$38
Aug-06-25	Upgrade	Raymond James	Mkt Perform → Outperform	$35
Jul-22-25	Resumed	Stephens	Equal-Weight	$35
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Show Previous Ratings

Apr-07-26 08:15AM	Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution (PR Newswire)
Mar-06-26 12:10AM	Azenta Details Turnaround at Raymond James Conference, Targets Margin Gains and Recurring Revenue Growth (MarketBeat)
Mar-04-26 09:11AM	Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities (PR Newswire)
Mar-02-26 11:07PM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory) -5.03%
Feb-26-26 11:40PM	1 Small-Cap Stock to Research Further and 2 Facing Headwinds (StockStory)
04:05PM	Loading…
Feb-24-26 04:05PM	Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference (PR Newswire)
Feb-13-26 09:33AM	Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release? (Zacks)
Feb-11-26 12:36AM	The Top 5 Analyst Questions From Azenta's Q4 Earnings Call (StockStory)
Feb-09-26 04:05PM	Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure (PR Newswire)
Feb-05-26 08:00AM	Stocks making big moves yesterday: Azenta, FTAI Aviation, Reddit, Columbia Sportswear, and RenaissanceRe (StockStory)
12:33AM	AZTA Q4 Deep Dive: Operational Challenges and Turnaround Efforts Dominate Results (StockStory)
Feb-04-26 04:03PM	Azenta Inc (AZTA) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Focus ... (GuruFocus.com) -22.81%
12:25PM	Azenta (AZTA) Stock Trades Down, Here Is Why (StockStory)
10:10AM	Azenta Q1 Earnings Call Highlights (MarketBeat)
09:59AM	Azenta (AZTA) Q1 2026 Earnings Call Transcript (Motley Fool)
08:12AM	Loading…
08:12AM	Azenta's (NASDAQ:AZTA) Q4 CY2025: Beats On Revenue (StockStory)
06:30AM	Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 (PR Newswire)
Feb-02-26 10:17PM	Azenta (AZTA) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jan-21-26 04:05PM	Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast (PR Newswire)
Jan-08-26 04:48AM	New Strong Sell Stocks for January 8th (Zacks)
Jan-05-26 03:45PM	Why Are Azenta (AZTA) Shares Soaring Today (StockStory) +7.07%
Dec-31-25 09:01AM	Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day (Zacks)
04:00AM	Bear of the Day: Azenta (AZTA) (Zacks)
Dec-30-25 08:05AM	Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M (TipRanks)
03:12AM	New Strong Sell Stocks for December 30th (Zacks)
Dec-29-25 08:00AM	Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L. (PR Newswire)
Dec-28-25 11:02PM	Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-15-25 05:46AM	New Strong Sell Stocks for Dec. 15 (Zacks)
Dec-10-25 12:43PM	Azenta Authorizes $250 Million Share Repurchase Program (PR Newswire)
Dec-09-25 05:51AM	New Strong Sell Stocks for December 9th (Zacks)
11:32PM	Loading…
Dec-02-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Nov-27-25 10:32PM	Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks (StockStory)
Nov-24-25 01:01PM	Why Azenta (AZTA) Stock Is Trading Up Today (StockStory) +5.19%
Nov-22-25 12:30AM	AZTA Q3 Deep Dive: Operational Discipline and Product Strength Support Margin Expansion (StockStory)
Nov-21-25 05:16PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +16.30% +5.19%
04:00PM	Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
06:41AM	Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales (StockStory)
06:30AM	Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 (PR Newswire)
Nov-19-25 10:01PM	Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Nov-12-25 04:05PM	Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 06:05PM	TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-05-25 07:05PM	Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 04:05PM	Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer (PR Newswire)
Oct-15-25 08:00AM	Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana (PR Newswire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Sep-02-25 08:04AM	Here's What Pressured Azenta (AZTA) in Q2 (Insider Monkey)
Aug-25-25 11:36PM	Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2 (StockStory)
Aug-21-25 12:02AM	3 Reasons to Avoid AZTA and 1 Stock to Buy Instead (StockStory)
Aug-13-25 05:50PM	Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know (StockStory) +9.83%
12:13AM	The Top 5 Analyst Questions From Azenta's Q2 Earnings Call (StockStory)
12:11AM	AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter (StockStory)
Aug-07-25 03:36PM	Why Azenta (AZTA) Stock Is Up Today (StockStory)
Aug-06-25 02:50PM	Azenta (AZTA) Stock Trades Up, Here Is Why (StockStory) +5.58%
Aug-05-25 12:40PM	Why Azenta (AZTA) Stock Is Trading Lower Today (StockStory) -17.00%
07:16AM	Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets (StockStory)
06:30AM	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
Aug-03-25 11:10PM	Azenta (AZTA) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 04:05PM	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
08:30AM	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
Jul-30-25 04:05PM	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-23-25 04:05PM	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-25 02:06PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +5.11%
Jul-17-25 11:31PM	Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jul-16-25 11:33PM	Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marotta John	President and CEO	Sep 10 '25	Sale	29.41	316	9,294	105,980	Sep 12 04:10 PM
Lin Lawrence Y.	EVP, CFO and Treasurer	Aug 11 '25	Buy	27.96	2,500	69,900	46,013	Aug 12 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZTA

Azenta Inc

Upgrade your Finviz experience